AlphaGrep UK Ltd’s Crocs CROX Stock Holding History

AlphaGrep UK Ltd’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$240K	Buy	2,893 +92	+3%	+$7.88K	0.07%	616
2025 Q4	$240K	Buy	+2,801	New	+$234K	0.08%	551

Other funds holding CROX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WPA

WIT Partners Advisory Singapore $213M AUM 9.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK Ltd's CROX Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Crocs (CROX) stake by 3.3% in Q1 2026, buying an estimated $7.88K and bringing the position to 2,893 shares worth $240K. The position accounts for 0.07% of the portfolio, ranked #616.

AlphaGrep UK Ltd first reported a position in CROX in Q4 2025 and has held it in 2 quarters since. 459 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

AlphaGrep UK Ltd held 2,893 shares of Crocs worth $240K as of Q1 2026.
AlphaGrep UK Ltd bought 92 Crocs shares in Q1 2026, an estimated $7.88K.
Crocs made up 0.07% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #616 holding.
AlphaGrep UK Ltd first reported a position in Crocs in Q4 2025 and has held it in 2 quarters since.
459 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.